|
Soler-Espejo E, Marco-Ayala J, Chen-Liang TH, Lopez-Poveda MJ, Teruel-Montoya R, Ortuno FJ. CD5+ follicular lymphoma rapidly transformed to high-grade B-cell lymphoma with double-hit: from BCL2 to MYC disruption. Blood Res. 2023 Mar 31;58(1):79-82. doi: 10.5045/br.2023.2023039. No abstract available. PubMed PMID: 36987619; PubMed Central PMCID: PMC10063588.
AÑO: 2023; IF: 2.2
|
36987619
|
Berna-Erro A, Ramesh G, Delgado E, Corbacho AJ, Ferrer-Marin F, Teruel R, Granados MP, Rosado JA, Redondo PC. CAPN1 (Calpain1)-Dependent Cleavage of STIM1 (Stromal Interaction Molecule 1) Results in an Enhanced SOCE (Store-Operated Calcium Entry) in Human Neonatal Platelets. Arterioscler Thromb Vasc Biol. 2023 May;43(5):e151-e170. doi: 10.1161/ATVBAHA.122.318015. Epub 2023 Mar 16. PubMed PMID: 36924231.
AÑO: 2023; IF: 7.4
|
|
Hurtado-Navarro L, Cuenca-Zamora EJ, Zamora L, Bellosillo B, Such E, Soler-Espejo E, Martinez-Banaclocha H, Hernandez-Rivas JM, Marco-Ayala J, Martinez-Alarcon L, Linares-Latorre L, Garcia-Avila S, Amat-Martinez P, Gonzalez T, Arnan M, Pomares-Marin H, Carreno-Tarragona G, Chen-Liang TH, Herranz MT, Garcia-Palenciano C, Morales ML, Jerez A, Lozano ML, Teruel-Montoya R, Pelegrin P, Ferrer-Marin F. NLRP3 inflammasome activation and symptom burden in KRAS-mutated CMML patients is reverted by IL-1 blocking therapy. Cell Rep Med. 2023 Dec 19;4(12):101329. doi: 10.1016/j.xcrm.2023.101329. PubMed PMID: 38118408; PubMed Central PMCID: PMC10772462.
AÑO: 2023; IF: 10.6
|
|
Bravo-Perez C, Cifuentes-Riquelme R, Padilla J, de la Morena-Barrio ME, Ortuno FJ, Garrido-Rodriguez P, Amigo ML, Heras I, Vicente V, Lozano ML, Teruel-Montoya R, de la Morena-Barrio B, Corral J. The whole is greater than the sum of its parts: Long-read sequencing for solving clinical problems in haematology. J Cell Mol Med. 2024 Feb;28(3):e17961. doi: 10.1111/jcmm.17961. Epub 2024 Jan 23. No abstract available. PubMed PMID: 38260950; PubMed Central PMCID: PMC10844759.
AÑO: 2024; IF: 4.2
|
|
Cuenca-Zamora EJ, Guijarro-Carrillo PJ, Lopez-Poveda MJ, Morales ML, Lozano ML, Gonzalez-Conejero R, Martinez C, Teruel-Montoya R, Ferrer-Marin F. miR-146a-/- mice model reveals that NF-kappaB inhibition reverts inflammation-driven myelofibrosis-like phenotype. Am J Hematol. 2024 Jul;99(7):1326-1337. doi: 10.1002/ajh.27322. Epub 2024 Apr 22. PubMed PMID: 38646919.
AÑO: 2024; IF: 9.9
|